Yahoo
NYSE American - Nasdaq Real Time Price USD

Picard Medical, Inc. (PMI)

8.35 +0.24 (+2.96%)
At close: October 30 at 4:00:00 PM EDT
8.29 -0.06 (-0.72%)
After hours: October 30 at 7:30:02 PM EDT
Chart Range Bar
Loading chart for PMI
  • Previous Close 8.11
  • Open 8.15
  • Bid 8.27 x 20000
  • Ask 8.78 x 20000
  • Day's Range 7.74 - 8.80
  • 52 Week Range 2.65 - 208.00
  • Volume 56,065
  • Avg. Volume 1,607,481
  • Market Cap (intraday) 19.528M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -7.14
  • Earnings Date (est.) Aug 14, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Zacks Rating Bullish

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.

www.picardmedical.com

75

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PMI
90.46%
S&P 500 (^GSPC)
10.73%

1-Year Return

PMI
94.91%
S&P 500 (^GSPC)
11.11%

3-Year Return

PMI
96.03%
S&P 500 (^GSPC)
81.91%

5-Year Return

PMI
96.03%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 2.95M
Earnings -5.66M
Profit Margin -191.60%

Q2

FY26

-4M
-2M
0
2M
-191.6%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -93.61%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    6.3M

  • Net Income Avi to Common (ttm)

    -26.42M

  • Diluted EPS (ttm)

    -7.14

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    38k

  • Total Debt/Equity (mrq)

    91.96%

  • Levered Free Cash Flow (ttm)

    -22.79M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: